Skip to content

Comparison of relaxation training and Valerian on insomnia of menopause women

Comparison of relaxation training and Valerian on insomnia of menopause women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014022516743N1
Enrollment
129
Registered
2014-04-12
Start date
2014-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia. Nonorganic insomnia

Interventions

Intervention 1: Valerian group, taken twice a day capsules of 530 mg Valerian, oral capsule Sedamin before bed for a month. Intervention 2: Relaxation training, participation in classes 2 times a day
Treatment - Drugs
Valerian group, taken twice a day capsules of 530 mg Valerian, oral capsule Sedamin before bed for a month
Relaxation training, participation in classes 2 times a day for the first week and then do the exercises at home
Control group, placebo containing Starch 50 mg 2 times a day for a month

Sponsors

Vice chancellor for Research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Main inclusion criteria : 1 ) at least one year has passed since the last menstrual discontinued after natural menopause; 2 ) lack of mental and physical diseases such as musculoskeletal disorders or paralysis, and…; 3 ) lack of sedative drugs; 4) the lack of smoking and alcohol: 5 ) failure , liver disease , kidney and gastrointestinal: 6 ) no history of cancer; 7 ) not using hormone therapy within 3 months ; 8 ) not suffering from high blood pressure . Exclusion criteria included : 1 ) the creation of any physical illness and mental During the study period , causing obstructive sleep apnea; 2 ) the emergence of a significant change sleep conditions as unpredictable as travel , shift or taking any medications , and additional material during study; 3 ) Do not use Valerian maximum period of seven consecutive days during the study period 4 ) unwillingness to cooperate.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Insomnia. Timepoint: Early intervention and after 1 month in all three groups. Method of measurement: Standardized questionnaire Petersburg.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzam Jokar

Fatemeh (PBUH) College of Nursing and Midwifery

Jokarhs@yahoo.com+98 71 1647 4258

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026